Altogether, this rapidly evolving evidence on the usefulness of liquid biopsy and miRNAs in cancer management stimulated our research group to design and conduct a prospective observational study, which is nearing completion, based on the idea of performing miRNA profiling in liquid biopsies and quantifying tissue-level gene expression in BC patients treated with CDK4/6 inhibitors. Here, CDK4 is linked to breast cancer.